Back To Schedule
Wednesday, March 6 • 6:00pm - 8:00pm
Promoting Excellence in R&D for Global Health FULL

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Limited Capacity seats available



The goal of this session is to showcase successful avenues for excellence in research and development for Global Health, with a particular focus on the benefits of international and cross-sectorial cooperation. While negotiations on Horizon 2020 continue, financing for research and development for Global Health will be addressed primarily by the EDCTP, but also ERC and possibly IMI. We would look at how these instruments are generating opportunities to expand and accelerate R&D for PRNDs by rewarding scientific excellence and fostering the collaboration between partners with distinct areas of expertise and capacities.

avatar for Maria Da Graça Carvalho

Maria Da Graça Carvalho

Member of the European Parliament
Maria da Graça Carvalho is a member of the European Parliament in the PPE group since 14 July 2009 (member of the ITRE-Industry, Research and Energy Committee, substitute member of the Budgets Committee and member of the ACP-UE Joint Parliamentary Assembly). She was elected co- President... Read More →
avatar for Karen Hoehn

Karen Hoehn

Vice Executive Director and Director of International Affairs, DSW, Deutsche Stiftung Weltbevölkerung
Karen Hoehn, Vice Executive Director and Director of International Affairs working with the German Foundation for World Population (DSW) since 2005, has 25 years experience influencing public policy and leveraging resources. Based first in Washington, DC and then Brussels, Belgium... Read More →

avatar for Theodore Papazoglou, Ph.D.,

Theodore Papazoglou, Ph.D.,

Head of Unit, Support to the European Research Council Scientific Council, ERC Executive Agency
Theodore G. Papazoglou graduated with honors from the Physics Department of the University of Crete, Greece in 1985 and followed his graduate studies at the University of Southern California (PhD in Biomedical Engineering in 1990). After his post-doctoral training at the Cedars Sinai... Read More →
avatar for Sally Ethelston

Sally Ethelston

Director, Communications and Advocacy PATH Malaria Vaccine Initiative (MVI)
Sally Ethelston is Director, Communications and Advocacy with the PATH Malaria Vaccine Initiative (MVI). MVI was established as a program of PATH in 1999, to accelerate the development of malaria vaccines and catalyze timely access in endemic countries. MVI's vision is a world free... Read More →
avatar for Prof Bruno Gryseels

Prof Bruno Gryseels

Director of the Institute of Tropical Medicine (ITM) at Antwerp
Bruno M.A.J. Gryseels studied medicine at the State University of Ghent (1972-1979), and Tropical Medicine and Hygiene at the ITM in Antwerp (1979). He obtained his PhD at the University of Leiden (NL) in 1990. After his studies he joined the ITM as a researcher in the Department... Read More →
avatar for Dr. Line Matthiessen

Dr. Line Matthiessen

Head of Unit - Infectious Diseases and Public Health, DG Research & Innovation, European Commission
Dr. Line Matthiessen leads the Unit responsible for Infectious Diseases and Public Health in the Directorate-General for Research and Innovation. The Unit promotes and supports EU research and innovation activities in the area of global health issues with emphasis on HIV/AIDS, malaria... Read More →
avatar for Dr Fil Randazzo

Dr Fil Randazzo

Deputy Director Global Health Discovery and Translational Science, Bill and Melinda Gates Foundation
Fil Randazzo currently serves as Deputy Director of Global Heath Discovery and Translational Sciences at the Bill & Melinda Gates Foundation where he is charged with managing a broad array of programs. Mr. Randazzo has recently been leading the development of the Vaccine Discovery... Read More →
avatar for Ms Elisabetta Vaudano

Ms Elisabetta Vaudano

Principal Scientific Manager, Innovative Medicines Initiative
Italian born Elisabetta Vaudano works as coordinator of the Scientific Pillar at the Innovative Medicines Initiative (IMI), the largest Public Private partnership in Health Sciences with a total budget of 2 billion EUR. Ms. Vaudano is a doctor in veterinary medicine and has a PhD... Read More →

Wednesday March 6, 2013 6:00pm - 8:00pm CET
European Parliament A3F383

Attendees (2)